Author: Ken Dropiewski

BioSig Announces Reduction of its Workforce

Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) — — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company, today announced that it has terminated a significant number of its employees and expects to substantially reduce business operations. About BioSig Technologies, Inc. BioSig Technologies is a medical […]

Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 fourth quarter and full year ended December 31, 2023 on Monday, March 4, 2024 at […]

Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients

MILFORD, Mass.–(BUSINESS WIRE)–Reprieve Cardiovascular, Inc., a development stage company focused on pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart failure (ADHF) treatment, today announced it has raised a total of $42 million in series A financing. The total round was co-led by Lightstone Ventures and […]

AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million

LATHAM, N.Y., February 15, 2024–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it has completed the sale of its PICC and Midline […]

Life Line Screening, Nationwide Cardiovascular Health & Stroke Risk Screening Company, Announces Amanda Rangel as Senior Vice President of Global Business Solutions

AUSTIN, Texas–(BUSINESS WIRE)–Life Line Screening, the nation’s leading provider of mobile preventive health screenings for cardiovascular disease and stroke risk is pleased to announce the appointment of Amanda Rangel as Senior Vice President of Global Business Solutions. With her rich background in fostering corporate relationships, Amanda’s expertise will be instrumental as Life Line Screening broadens its commercial outreach. Amanda Rangel comments on her new role: “I’m thrilled to join L

RapidAI Announces Late-Breaking Abstract Simultaneously Published in NEJM; Highlights Key Data Revealed at ISC 2024

SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced the publication of the TIMELESS trial in the New England Journal of Medicine (NEJM). Other select data from research studies unveiled last week at the […]

Canary Completes First-in-Human Trial of Cardiac Auscultation Monitoring Sensor

The Cardiac Auscultation monitoring device was trialed for use with heart failure patients as an adjunct to care in monitoring the effectiveness of congestive heart failure medication management The limited clinical trial represents the first human implantation of a cardiac auscultation sensor device Heart failure affects one in five people, […]